Synergism of Immunomodulation and Tumor Ablation
Clinical trial NCT03101475 · COMPLETED
Trial details
- NCT number
- NCT03101475
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-23
- Primary completion
- 2021-03-03
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.